AGL 23.47 Decreased By ▼ -0.93 (-3.81%)
AIRLINK 106.11 Decreased By ▼ -3.18 (-2.91%)
BOP 5.17 Decreased By ▼ -0.12 (-2.27%)
CNERGY 3.66 Decreased By ▼ -0.01 (-0.27%)
DCL 7.80 Decreased By ▼ -0.20 (-2.5%)
DFML 44.19 Decreased By ▼ -0.11 (-0.25%)
DGKC 88.50 Decreased By ▼ -0.30 (-0.34%)
FCCL 21.75 Decreased By ▼ -0.24 (-1.09%)
FFBL 42.52 Increased By ▲ 0.24 (0.57%)
FFL 8.75 Decreased By ▼ -0.15 (-1.69%)
HUBC 147.80 Decreased By ▼ -3.90 (-2.57%)
HUMNL 10.25 Decreased By ▼ -0.10 (-0.97%)
KEL 4.34 Decreased By ▼ -0.11 (-2.47%)
KOSM 3.79 Decreased By ▼ -0.16 (-4.05%)
MLCF 36.40 Decreased By ▼ -0.20 (-0.55%)
NBP 49.30 Increased By ▲ 0.14 (0.28%)
OGDC 130.85 Decreased By ▼ -0.85 (-0.65%)
PAEL 25.95 Decreased By ▼ -0.36 (-1.37%)
PIBTL 6.05 Decreased By ▼ -0.02 (-0.33%)
PPL 114.55 Decreased By ▼ -0.90 (-0.78%)
PRL 22.60 Decreased By ▼ -0.07 (-0.31%)
PTC 12.37 Decreased By ▼ -0.13 (-1.04%)
SEARL 55.70 Decreased By ▼ -0.49 (-0.87%)
TELE 7.25 Decreased By ▼ -0.15 (-2.03%)
TOMCL 36.40 Decreased By ▼ -1.29 (-3.42%)
TPLP 7.95 Decreased By ▼ -0.39 (-4.68%)
TREET 15.29 Decreased By ▼ -0.04 (-0.26%)
TRG 56.70 Decreased By ▼ -3.26 (-5.44%)
UNITY 31.85 Decreased By ▼ -0.49 (-1.52%)
WTL 1.17 Decreased By ▼ -0.01 (-0.85%)
BR100 8,272 Decreased By -134.4 (-1.6%)
BR30 26,048 Decreased By -405.8 (-1.53%)
KSE100 78,469 Decreased By -927.7 (-1.17%)
KSE30 25,198 Decreased By -319.9 (-1.25%)

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed.